SCHEMBL13664702

SCHEMBL13664702

O=C1CNCCCN1c1ccccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.58
SLC6A4 P31645 2/20 0.58
SLC6A3 Q01959 2/20 0.58
ADRB1 P08588 2/20 0.49
CYBB P04839 2/20 0.48
NOX5 Q96PH1 2/20 0.48
NOX4 Q9NPH5 2/20 0.48
NOX1 Q9Y5S8 2/20 0.48
ALOX5 P09917 2/20 0.44
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
P2RX7 Q99572 2/20 0.40
ALB P02768 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814949 0.90 ADRB1 (0.56) SLC6A2SLC6A4SLC6A3ADRB1CYBB
Hydrochloric Acid SCHEMBL1663296 0.89 ADRB1 (0.54) SLC6A2SLC6A4SLC6A3ADRB1CYBB
SCHEMBL13664823 0.85 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3ADRB1CYBB
SCHEMBL13664710 0.82 SLC6A2 (0.63) SLC6A2SLC6A4SLC6A3CYBBNOX5
SCHEMBL25575696 0.79 ADRB1 (0.49) ADRB1CYBBNOX5NOX4NOX1
SCHEMBL5436101 0.78 ALOX5 (0.54) ALOX5P2RX7ALBADRA1DADRA1A
SCHEMBL13664716 0.78 SLC6A2 (0.58) SLC6A2SLC6A4SLC6A3CYBBNOX5
SCHEMBL5480292 0.77 SLC6A2 (0.60) SLC6A2SLC6A4SLC6A3ADRB1ALOX5
SCHEMBL13664891 0.76 SLC6A2 (0.59) SLC6A2SLC6A4SLC6A3CYBBNOX5
SCHEMBL20103130 0.76 ADRA1A (0.48) ALOX5P2RX7ALBADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009119528-A1 HETEROCYCLIC COMPOUND 武田薬品工業株式会社 (JP) 2009-10-01 WO disclosed